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Recent studies in chick and mouse embryos have identified a previously unrecognized secondary heart field (SHF), located in the ventral
midline splanchnic mesenchyme, which provides additional myocardial cells to the outflow tract as the heart tube lengthens during cardiac
looping. In order to further delineate the contribution of this secondary myocardium to outflow development, we labeled the right SHF of
Hamburger–Hamilton (HH) stage 14 chick embryos via microinjection of DiI/rhodamine and followed the fluorescently labeled cells over a
96-h time period. These experiments confirmed the movement of the SHF into the outflow and its spiraling migration distally, with the right
side of the SHF contributing to the left side of the outflow. In contrast, when the right SHF was labeled at HH18, the fluorescence was limited
to the caudal wall of the lengthening aortic sac. We then injected a combination of DiI and neutral red dye, and ablated the SHF in HH14 or
18 chick embryos. Embryos were allowed to develop until day 9, and harvested for assessment of outflow alignment. Of the embryos ablated
at HH14, 76% demonstrated cardiac defects including overriding aorta and pulmonary atresia, while none of the sham-operated controls were
affected. In addition, the more severely affected embryos demonstrated coronary artery anomalies. The embryos ablated at HH18 also
manifested coronary artery anomalies but maintained normal outflow alignment. Therefore, the myocardium added to the outflow by the SHF
at earlier stages is required for the elongation and appropriate alignment of the outflow tract. However, at later stages, the SHF contributes to
the smooth muscle component of the outflow vessels above the pulmonary and aortic valves which is important for the development of the
coronary artery stems. This work suggests a role for the SHF in a subset of congenital heart defects that have overriding aorta and coronary
artery anomalies, such as tetralogy of Fallot and double outlet right ventricle.
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Elongation of the midline heart tube is an important
morphological process during formation of a four-cham-
bered heart. Elongation provides the length that the tube
needs for convergence of the inflow and outflow ends, and
subsequently for the outflow tract to wedge between the
right and left atrioventricular valves. Wedging is an
important step because it brings the pulmonary trunk and0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: mlkirby@duke.edu (M.L. Kirby).aorta into the correct alignment with the right and left
ventricular outlets, respectively. Failure of wedging leads to
congenital heart malformations like tetralogy of Fallot and
double outlet right ventricle (Yelbuz et al., 2002).
Several labs described the existence of a ‘‘secondary’’ or
‘‘anterior’’ heart field that serves as a source of myocardial
cells to lengthen the outflow end of the tubular heart (Kelly
et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001).
The secondary heart field (SHF) is located in the
mesenchyme of the ventral pharynx between the inflow
and outflow tracts. After neural crest ablation in the chick
embryo, the myocardium is not added from the secondary
heart field and the hearts have malaligned outflow tracts
(Yelbuz et al., 2002; Waldo et al., 2005b).284 (2005) 72 – 83
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somite 3 in chick embryos) results in cardiac defects, most
commonly persistent truncus arteriosus (PTA). These PTAs
are also malaligned since the truncus originates predom-
inately from the right ventricle. In the neural-crest-ablated
embryos that do not develop PTA, there are other defects of
cardiac outflow alignment, namely, double outlet right
ventricle and tetralogy of Fallot (Kirby et al., 1983) The
alignment defects in addition to problems with septation
suggest two separate anomalous processes seen after neural
crest ablation. Further experiments with HIRA, a chromo-
somal remodeling gene expressed in neural crest cells,
demonstrated that the malalignment of the outflow tract
after neural crest ablation could indeed be separated from
the septation defect, as embryos treated with antisense
oligonucleotides to HIRA developed PTAs with normal
alignment (Farrell et al., 1999a,b, 2001). Although the
septation defect could be easily explained by the absence of
the neural crest cells responsible for the formation of the
aorticopulmonary septum, the origin of the alignment defect
required further investigation. In a recent study, Yelbuz et al.
(2002) proposed that the length of the outflow tract was
affected by neural crest ablation. Using videocinephotog-
raphy, scanning electron microscopy, and histological
sections to assess outflow morphology, neural-crest-ablated
embryos were found to have malpositioning of the inflow
and outflow limbs, a diminished inner curvature, and a
straighter and ventrally displaced outflow limb, all of which
were consistent with a shorter outflow tract (Yelbuz et al.,
2002). The reduced length was thought to be the result of a
decreased contribution from the secondary heart field, an
area of ventral midline splanchnic mesenchyme known to
add myocardium to the developing outflow tract. HNK1
staining of neural-crest-ablated embryos at Hamburger–
Hamilton (HH) stage 16 demonstrated drastically reduced
migration of cells from the SHF into the developing outflow
(Cai et al., 2003; Kelly et al., 2001; Mjaatvedt et al., 2001;
Yelbuz et al., 2002). We therefore hypothesized that failure
of cells to be added to the outflow tract from the SHF may
be responsible for the defects of cardiac outflow alignment
seen after neural crest ablation, since the shorter outflow
tract is unable to undergo the rotation necessary for
appropriate alignment of the aorta and pulmonary trunk
with their respective ventricles.
To further investigate the role of the SHF in formation of
the outflow tract, we labeled the SHF in HH14 chick
embryos prior to its addition to the outflow tract and
monitored the movement of the marked cells. These data
confirmed the movement of the SHF into the developing
outflow tract and also demonstrated that the right SHF
spirals behind and to the left side of the conotruncal junction
within the inner curvature. We then used a nitrogen-dye
laser to ablate the right SHF of HH14 chick embryos.
Defects of cardiac outflow alignment, as well as stenotic or
atretic pulmonary trunks were found, confirming a role for
the SHF in the appropriate alignment of the outflow, as wellas a role for the right SHF in formation of the pulmonary
(left) side of the outflow. We also performed labeling
experiments as well as ablations of the right SHF in older
HH18 embryos in which the myocardium of the SHF has
already been added. These embryos demonstrated normal
outflow alignment, confirming that the myocardial addition
from the SHF is complete by HH18. Of note, the embryos
ablated at HH18, as well as those most severely affected by
ablations at HH14, possessed coronary artery anomalies.
Other work in our laboratory demonstrates that, at later
stages, the SHF adds smooth muscle to the developing
outflow tract (Waldo et al., 2005a). The coronary artery
anomalies seen in SHF-ablated embryos suggest that this
smooth muscle addition is important for correct formation of
the coronary artery stems.Materials and methods
Embryos
Fertilized Ross Hubert chicken eggs (Goldkist Hatchery,
Siler City, NC) were incubated at 37-C and 70% relative
humidity until they reached the desired Hamburger–
Hamilton stage (Hamburger and Hamilton, 1951). For
shell-less cultures, embryos were transferred to hexagonal
polycarbonate weigh boats which were placed in 15-cm
Petri dishes with 0.5 cm of distilled water in the bottom.
These were reincubated at 37-C and 70% relative humidity.
In situ hybridization and sectioning of stained embryos
An Nkx2.5 digoxygenin-labeled riboprobe was generated
from a 221-bp fragment of the chick Nkx2.5 cDNA as
previously described (Waldo et al., 2001). Whole mount in
situ hybridization was carried out using the protocol
described by Wilkinson (1992). After examination and
documentation of whole mount staining, the embryos were
embedded in paraffin, sectioned transversely at 12 Am, and
mounted.
Microinjections
HH14 or 18 chick embryos were placed in shell-less
culture and back-injected with green tissue marking dye
(Triangle Biomedical Services) for better visualization of
the pharynx. For the labeling experiments, DiI (Molecular
Probes) was dissolved in DMSO at a concentration of 2.5
mg/ml. Tetramethylrhodamine-succinyl ester (TAMRA-SE,
Molecular Probes) or carboxyfluorescein diacetate (CFSE,
Molecular Probes) was dissolved in 100% ethanol at a
concentration of 10 mg/ml. DiI and TAMRA-SE were then
diluted 1:1:10 with normal saline. Pulled capillaries were
used to inject approximately 1–2 nl of the diluted DiI/
TAMRA-SE mixture into the right SHF. The injected
embryos were incubated at 37-C and 70% relative humidity
C. Ward et al. / Developmental Biology 284 (2005) 72–8374until the desired time points of 24, 48, or 96 h after the
injection. After examination and documentation of whole
mount fluorescence, the embryos were fixed in 4%
phosphate-buffered paraformaldehyde (PFA) for 24 h at
4-C. The embryos were processed for paraffin embedding,
sectioned, and double immunostained for rhodamine and
myocardium (MF20).
SHF ablations
DiI was dissolved as described above. Neutral red was
dissolved in normal saline at a concentration of 0.4%. Using
the techniques described above, neutral red alone or a
mixture of neutral red plus DiI was microinjected into the
right SHF of HH14 or HH18 chick embryos. Ablations were
performed using a pulsed nitrogen-dye laser both in shell-
less culture and in ovo. Sham-operated embryos were
injected as described above and returned to the incubator.
Ablated and sham embryos were incubated at 37-C and
70% relative humidity until the desired developmental
stage. A series of embryos was allowed to develop until
day 9 to determine the gross morphology of the fully
septated heart. Hearts were harvested and immersion fixed
in 10% formalin overnight. After examination and doc-
umentation of gross morphology, hearts were embedded in
paraffin, sectioned, and mounted. Sections were stained
with 0.5% thionine or hematoxylin and eosin.
Sytox green staining
Ablation of the SHF was performed as described above.
The embryos were incubated for 1 h at 37-C and harvested
in normal saline. Embryos were then stained in Sytox Green
(1 AM, Molecular Probes) to label the laser-damaged SHF
for 10 min. After examination and documentation of whole
mount staining, embryos were fixed in 4% PFA for 10 min
at 4-C. The embryos were then taken through a series of
sucrose gradients, embedded in OCT, and cryosectioned.
Immunohistochemistry
SHF-ablated and sham-operated embryos were harvested
at HH25/26, embedded in paraffin and sectioned at 8 Am. The
sections were incubated as described previously (Waldo et al.,
1996, 1998). HNK-1 (obtained from American Type Culture
Collection) was visualized with Alexa 488 goat anti-mouse
IgG conjugate (Molecular Probes) as reported previously
(Waldo et al., 1996, 1998). MF20 was obtained from the
Developmental Studies Hybridoma Bank developed under
the auspices of NICHD and maintained by the University of
Iowa, Department of Biological Sciences, Iowa City, IA.
MF20 was visualized with Alexa 568 goat anti-mouse IgG
conjugate. For the staining with factor-VIII-related antigen,
SHF-ablated embryos were harvested at day 9 of develop-
ment, fixed in Serra’s solution, embedded in paraffin, and
incubated as described previously (Ribatti et al., 1999).Antibody to factor-VIII-related antigen was obtained from
DakoCytomation and used at a 1:250 dilution. The rabbit
ABC Elite kit (Vector) was used for the secondary reaction
with DAB visualization. The preparations were counter-
stained with hematoxylin (Anatech, Battle Creek, MI).Results
NKX2.5 expression in the developing heart and SHF
In order to better delineate the putative boundaries of the
SHF, we performed in situ hybridization of Nkx2.5 (Fig. 1),
a transcription factor known to be expressed in early
myocardial precursor cells as well as the SHF (Waldo et
al., 2001), at HH12–24 (Hamburger and Hamilton, 1951).
At all stages, Nkx2.5 was expressed throughout the length
of the heart tube (Fig. 1A). At HH12, extracardiac Nkx2.5
expression was notable in ventral pharyngeal mesenchyme
both cranial and caudal to the junction of the outflow tract
with the ventral pharynx (Figs. 1A–C). Nkx2.5 expression
caudal to the connection of the outflow tract with the body
wall, which represents the SHF, extended to the juncture of
the inflow portion of the linear heart tube with the body
wall. Diffuse expression was maintained at HH14 (Figs.
1D–F), as the linear heart tube proceeded with looping. At
HH16, the Nkx2.5 expression increased in intensity in the
SHF, but disappeared from the region cranial to the outflow
(Fig. 1G). At HH18 (Figs. 1H and I), the amount of Nkx2.5
expression decreased in the region caudal to the outflow and
was seen only in the area surrounding the attachment of the
outflow with the ventral pharynx. This pattern of limited
Nkx2.5 expression was unchanged at later stages up to
HH24 (data not shown). The decrease in the size of the area
of Nkx2.5 expression caudal to the outflow starting at HH18
coincided with the decrease in addition of cardiac precursor
cells to the developing outflow tract from the SHF (Waldo et
al., 2001), suggesting that the addition of myocardium may
be complete by HH18 since the pattern remained unchanged
at later stages.
The right side of the SHF contributes to the left side of the
outflow myocardium
In order to better understand the mechanics of the
addition of myocardial cells from the SHF to the developing
outflow, we performed labeling experiments using DiI/
rhodamine. Because the chick embryo lies on its right side
after HH13, the left side is not reliably accessible for
physical marking; thus, all of the marking experiments were
done in the right SHF. The right side of the SHF of HH14
chick embryos in shell-less culture was microinjected with
DiI/rhodamine, and fluorescence followed at 4-h intervals to
24, 48, and 96 h. After 24 h, the DiI/rhodamine-labeled cells
migrated into the distal caudal outflow myocardium (Figs.
2A, B). At 48 h, labeled cells were seen in the caudal left
Fig. 1. Nkx2.5 expression in the developing heart and SHF. (A) In situ hybridization of Nkx2.5 in an HH12 embryo demonstrating expression in the heart tube
and in the ventral pharynx surrounding and caudal to the juncture of the outflow tract with the pharyngeal wall. The positive region behind the outflow (arrow)
is the SHF. (B) Section of HH12 embryo demonstrating that Nkx2.5 expression is in the ventral pharyngeal mesenchyme (arrow). (C) Higher magnification of
area in box in panel B. (D) Expression domain of Nkx2.5 at HH14. The region of the SHF is marked by the arrow. (E) Section of HH14 embryo showing
Nkx2.5 expression in the ventral pharyngeal mesenchyme (arrow). (F) Higher magnification of the area in the box in panel E. (G) HH16 embryo demonstrating
Nkx2.5 expression is now concentrated in the ventral pharyngeal mesenchyme caudal to the outflow tract. (H) At HH18, expression of Nkx2.5 is limited to the
area caudal to the connection of the outflow tract with the ventral pharynx. (I) Transverse section through the caudal outflow tract of HH18 embryo
demonstrating Nkx2.5 expression (arrow). PA1 = pharyngeal arch 1, Ph = pharynx, OFT = outflow tract, At = atrium.
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attachment to the pharynx and presumptive right ventricle
(Fig. 2C). By 96 h, the DiI-labeled cells were found at the
base of the outflow on the left side which after septation, but
prior to wedging of the aorta between the atrioventricular
valves, becomes the pulmonary side of the outflow (Figs.
2D, E). These data show that cells from the SHF migrate
from the ventral pharyngeal mesenchyme into the develop-
ing outflow with the right side of the SHF contributing
myocardium to the left or future pulmonary side of the
outflow. To determine whether cells were moving into the
myocardial plane of the outflow tract from areas cranial to
and surrounding the outflow tract, we simultaneously
labeled the SHF (Fig. 2F, red) and the ventral pharyngeal
mesenchyme at the level of arch 1 or 2 (Fig. 2F, green).
While the SHF cells began their migration into the outflow
tract on the myocardial plane at 24 h, the cells labeled at the
level of arch 1 or 2 remained in place or moved into the
outflow tract on the endocardial or cardiac jelly tissue planes
(Fig. 2G, no green can be seen in the outflow tract).Histological sections show rhodamine labeling on the
myocardial plane, although no fluorescein could be detected
(Fig. 2H). These results indicate that even though Nkx2.5 is
expressed in arches 1 and 2 cranial to the outflow tract at
HH14, the only Nkx2.5-expressing cells that contribute to
the myocardium after HH14 are derived from the SHF,
which is located behind the outflow tract.
Ablation of the right SHF leads to pulmonary atresia
Neural crest ablation interferes indirectly with the addition
of the myocardium from the SHF to the outflow; however, it
is not known what the direct consequences are to heart
development when addition of the SHF-derived myocardium
is directly perturbed. In order to further elucidate the
contribution of the SHF to the developing heart, we ablated
the right side of the SHF in HH14 chick embryos. Using the
microinjection techniques developed above, the right side of
the SHF was first microinjected with DiI and neutral red to
aid targeting of the laser, and then ablated using a pulsed
Fig. 2. Right SHF adds to the left side of the preseptation outflow myocardium. Right SHF of HH14 chick embryos labeled with DiI/rhodamine (A)
immediately after the injection. (B) 24 h after label of SHF demonstrating movement of cells into outflow tract viewed from the left side. (C) Left view of a
heart 48 h after marking showing fluorescent cells now in the mid-portion of the caudal wall of the outflow tract and moving toward the left side. (D) 96 h after
labeling, cells are located at base of the outflow on the left side above the left ventricle in this ventral view of the heart. The atria have been removed. (E)
Higher magnification of boxed area in panel D to see labeled cells as base of outflow tract. (F) Time 0 of right SHF labeled with DiI/TAMRA-SE (red) and
ventral pharyngeal mesenchyme at level of arch 2 labeled with CF-SE (green). (G) 24-h time point of labeling shows the red-labeled SHF adding to the outflow
while mesenchyme from arch 2 (green) does not. (H) Section of labeled embryo at the 24-h time point demonstrates red labeling in the myocardial wall but no
green-labeled cells have moved into the outflow tract from pharyngeal arch 2. OV = otic vesicle, OFT = outflow tract, PA2 = pharyngeal arch 2, PT =
pulmonary trunk, Ao = aorta, LV = left ventricle, RV = right ventricle, L = lumen.
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ablation, we allowed the embryos to incubate for 1 h and then
stained with SyTox Green which marks cell necrosis. The
necrotic area was found in the ventral pharynx just caudal to
the outflow at the level of pharyngeal arch 3, and co-localized
with the DiI marking (Fig. 3A). In addition, sections of the
Sytox green-stained embryos confirmed that the ablation was
in the ventral pharyngeal mesoderm and involved only the
right side of the SHF (Fig. 3B). Using the same ablation
technique, a series of embryos with SHF ablations were
allowed to develop until day 9 and the hearts were harvested
for evaluation of gross morphology. Figs. 3C–F depict the
variety of phenotypes found. Most commonly, the aorta and
pulmonary trunk were oriented in a side-by-side fashion (Fig.
3E), with the aorta to the right of the pulmonary trunk rather
than wedged behind it. In the more severe cases, thepulmonary trunk was drastically reduced in size (Fig. 3D)
and in some cases completely missing (Fig. 3F). The hearts
were then sectioned and stained with H&E or thionine to
more accurately assess morphology. Sections revealed
ventricular septal defects in the affected hearts (compare
Fig. 4B with Figs. 4E, G arrows). The side-by-side
orientation of the aorta and pulmonary trunk was more
obvious in histological sections (compare Fig. 4C with Fig.
4F). The reduced size of the pulmonary trunk as compared to
the aorta was also more apparent (Fig. 4F). Figs. 4G–I
represent the most severe phenotype in which there was
complete atresia of the pulmonary trunk. Here, the aortic
outflow tract formed and communicated with both ventricles
by way of a large VSD (Figs. 4J–L). No pulmonary
infundibulum was formed, leaving the aorta as the common
outflow for both right and left ventricles. The aortic valve was
Fig. 3. Ablation of the right SHF results in overriding aorta and pulmonary atresia. (A) Sytox green staining of embryo after laser ablation demonstrating
necrosis in the SHF. The red fluorescent DiI label was used to target the laser and can be seen overlapping the green fluorescent necrotic area. (B) Section of the
embryo in panel A confirming that necrosis is in the ventral pharyngeal mesenchyme below the foregut (fg) and overlaps with the DiI label (yellow). Note that
the ablation only affects the right SHF. (C) Sham-operated embryo demonstrating normal alignment of outflow tract with the pulmonary trunk (PT) located
anterior to the aorta (Ao). (D) Right SHF-ablated embryo with side-by-side orientation of the PT and Ao and reduced size of the PT (arrow). (E) Right SHF-
ablated embryo with side-by-side orientation of the PT and Ao, demonstrating the overriding aorta. (F) Right SHF-ablated embryo with absent PT.
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malformation is pulmonary atresia and not persistent truncus,
since persistent truncus in the chick has four or more leaflets
at the ventriculoarterial junction. In total, we found that 76%
of embryos were affected by ablation of the SHF: 52% with
side-by-side orientation of the aorta and pulmonary trunks,
8% with reduced size of the pulmonary trunk, and 16% with
complete pulmonary atresia (Table 1). None of the sham
embryos were affected.
The role of the SHF at later stages of development
In situ hybridization indicated that the expression of
Nkx2.5 was reduced in the SHF after HH18, and we
therefore hypothesized that addition of myocardium by theSHF was complete by this stage of development. We
therefore marked the right side of the SHF behind the
outflow tract in HH18 embryos and monitored the migration
of the cells at 4-h intervals (Fig. 5A). The labeled cells did
not progress into the outflow myocardium as seen in
labeling experiments done at earlier stages, but instead
were found in the caudal wall of the lengthening aortic sac
which will contribute to the smooth muscle portion of the
outflow vessels above the aortic and pulmonary valves (Fig.
5B) (Waldo et al., 2005a,b). We then ablated the SHF at
HH18 using the methods described above. The later ablation
of the right SHF did not affect outflow alignment, since the
ablated embryos demonstrated appropriate wedging of the
aorta behind the pulmonary artery (Figs. 5C–H). These
results were not unexpected, since the addition of the early
Fig. 4. Histology of right SHF-ablated embryos. (A–C) Serial sections of sham-operated embryo demonstrating normal alignment of the pulmonary and aortic
outflow tracts, as well as normal alignment at valve level with the pulmonary trunk (PT) anterior to the aorta (Ao) (C). (D–F) Serial sections of right SHF-
ablated embryo with ventricular septal defect (VSD, arrow) and side-by-side orientation of pulmonary and aortic valves (F). (G– I) Serial sections of right SHF-
ablated embryo with a VSD (arrow) and an aortic outflow that communicates with both left and right ventricles (H). Note absence of right ventricular outflow
tract anterior to aortic outflow. At valve level, the aortic valve forms the only outflow for both ventricles and there is complete pulmonary atresia (I). (J) Frontal
section of sham-operated embryo demonstrating how the ventricular septum prohibits communication of the aorta and right ventricle. (K) Frontal section of
SHF-ablated embryo with side-by-side orientation to PT and Ao, as well as VSD (arrow) which allows communication of aorta with RV. (L) Frontal section of
SHF-ablated embryo with pulmonary atresia and VSD, allowing communication of Ao with RV. In panels J–L, asterisks are used to mark the coronary artery
ostia. PT = pulmonary trunk, Ao = aorta, RV = right ventricle, LV = left ventricle, Co = right ventricular conus, Ao V = aortic vestibule, RA = right atrium,
LA = eft atrium, VS = ventricular septum.
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lengthening of the outflow and the normal alignment of
the outflow with respect to the ventricles, was not disturbed.
Coronary artery anomalies after ablation of the SHF
The insertion of the coronary arteries into the aorta was
normal in embryos ablated at stage 14 that were onlymoderately affected with side-by-side orientation to the
outflow vessels (data not shown). However, in the more
severely affected hearts, coronary artery anomalies were
present (Fig. 6). Similar coronary anomalies were seen in
the embryos ablated at HH18, despite the fact that the aorta
and pulmonary trunk showed correct alignment (Figs. 5E–
H). The coronary anomalies seen included: two coronaries
originating from a single cusp (Fig. 6C), two coronaries
Table 1
Summary of cardiovascular phenotypes in embryos with secondary heart
field ablations
Sham (%) Ablated (%)
Affected 0 19 (76)
Overriding aorta 13 (52)
Pulm stenosis 2 (8)
Pulm atresia 4 (16)
Normal 100 6 (24)
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of either one or both coronary artery stems (Figs. 5E, F, and
6D, respectively). In the embryos with absent coronary
stems, multiple small endothelial channels were seen on the
periphery of the aorta (Fig. 6D, arrowheads). The identity of
these channels as endothelial in origin was confirmed byFig. 5. SHF ablations at HH18 have normal outflow alignment but coronary artery a
The labeled cells were located in the region caudal to the outflow in the region of th
wall of the aortic sac (view of the right side). (C, D) Sham-operated embryo dem
placement of the coronary artery stems (black arrows). (E, F) Embryo with right
aorta. The aorta has a single coronary artery (black arrow). (G, H) Embryo with
coronaries originate from a single ostium (black arrow). PA = pulmonary artery,staining with factor-VIII-related antigen, which marks the
endothelium of blood vessels in chick embryos starting at
day 8 of development (Figs. 6E–G) (Ribatti et al., 1999).
Coronary artery development in chick embryos occurs as
subepicardial endothelial channels grow into the aorta from
a ring of capillaries that surrounds the outflow vessels.
These channels eventually grow through the aortic wall to
become the coronary stems by day 7 of chick development
(Waldo et al., 1994). In the SHF-ablated embryos with
absent coronary stems, these endothelial channels were
indeed present at day 9 (Fig. 6D, arrowheads) but did not
form the coronary stems. Thus, these data suggest that,
without the addition of the smooth muscle component from
the SHF, these endothelial channels were unable to
appropriately target the right and left coronary sinuses of
the aorta and to form right and left coronary stems. Further,nomalies. (A) SHF labeling with DiI/fluorescein in HH18 embryo at time 0.
e 3rd arch. (B) 24 h after the injection, the cells have moved into the caudal
onstrating normal alignment of the aorta and pulmonary trunk and normal
SHF ablated at HH18 shows normal alignment of the pulmonary trunk and
right SHF ablated at HH18 and normal outflow tract alignment but both
Ao = aorta.
Fig. 6. Coronary anomalies in SHF-ablated embryos. (A, B) Sections of sham-operated embryo demonstrating normal coronary stems on the right and left sides
of the aorta (black arrows). (C) SHF-ablated embryo with both coronary stems from a single sinus. (D) Same embryo as shown in Figs. 4D–F showing absence
of coronary stems. Arrowheads mark coronary capillary network surrounding the base of the aorta. (E) SHF-ablated embryo stained with antibody to factor-
VIII-related antigen, which marks the endothelium. Asterisk marks coronary stem from the left sinus. Note absence of coronary on right side. (F) Higher
magnification of area indicated in panel E showing coronary stem with positive factor-VIII-related antigen staining (brown). (G) Same embryo as shown in
panels E and F demonstrating coronary capillary network (arrowheads) surrounding the base of the aorta on the right. Note the presence of the coronary seen on
left side (asterisk in E) and absence of coronary capillary network on left side in F. (H) Higher magnification of area indicated in panel G demonstrating
capillary network seen with positive staining of antibody to factor-VIII-related antigen (brown), confirming its endothelial identity. Ao = aortic valve, PT =
pulmonary trunk, CA = coronary artery.
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embryos in which the ablations were performed at HH18, it
appears that the later addition of the smooth muscle cells
from the SHF to the caudal wall of the aortic sac is
important for coronary artery development.Discussion
The present study outlines two roles for the SHF in
outflow tract development. At early stages, the SHF is
responsible for the addition of myocardium to lengthen the
myocardial outflow tract as our DiI/rhodamine labeling
studies document the movement of cells from the SHF into
the outflow and their migration toward the right ventricle.
This additional myocardium elongates the outflow and
provides length for appropriate looping. It also adds
spiraling myocardium that may accommodate the rotation
required for appropriate alignment of the aorta andpulmonary trunk with the left and right ventricles. During
the process of wedging, the aortic valve rotates behind the
pulmonary trunk and settles between the two atrioventric-
ular valves. In both neural-crest- and SHF-ablated embryos,
disrupted addition of the SHF results in malalignment of the
cardiac outflow tract. In the SHF-ablated embryos, the lack
of addition of the SHF-derived myocardium results in a
shorter outflow that cannot undergo rotation. Since septation
is normal, this results in an overriding aorta and side-by-side
orientation of the aorta and pulmonary trunk. Similarly, in
the neural-crest-ablated embryos, the SHF is not added and
outflow rotation does not occur; however, without neural
crest cells, the phenotype is additionally complicated by
lack of outflow septation, leading to a malaligned PTA. The
present study and that by Yelbuz et al. (2002) and Waldo et
al. (2005a,b) demonstrate that, in both cases, the defects in
cardiac outflow alignment are the result of disrupted
addition of the myocardium from the SHF. Another model
of tetralogy of Fallot has been created in chick by Watanabe
C. Ward et al. / Developmental Biology 284 (2005) 72–83 81and colleagues by preventing cell death in the outflow
myocardium as it is absorbed into the right ventricle
(Watanabe et al., 1998, 2001). Thus, both the generation
and remodeling of the outflow myocardium are critical to
proper alignment of the ventriculoarterial connection and
wedging of the aorta. In addition, defects high in the
ventricular septum were present in many of the embryos that
underwent SHF ablation. While these VSDs may occur
secondary to developmental pressures on the embryo from
the defects in outflow alignment, they may also be part of
the phenotype itself. We hypothesize that the secondary
heart field may contribute the myocardium necessary to
form the highest portion of the ventricular septum which is
directly connected to the great vessels. Also, the VSD could
result from an unbridgeable gap resulting from the malalign-
ment itself, since the outflow tract is not appropriately
positioned over the future right and left ventricles for
ventricular septal closure.
Our study also demonstrates that the myocardial addition
of the SHF takes place with a specific geometry in that the
right side spirals behind and into the left side of the outflow
tract. In the preseptation outflow tract, this represents the
future pulmonary outflow. It is not surprising, therefore, that
the ablation of the right SHF results in disruption of
development of the right ventricular outflow and pulmonary
trunk, either by reduction in size of the pulmonary outflow
(pulmonary stenosis) or complete pulmonary atresia. We
therefore hypothesize that the left side of the SHF adds to
the right side of the developing outflow and that ablation of
this side would lead to aortic stenosis or atresia. However,
testing this hypothesis will be difficult since the chick
embryo lies on its left side.
Nkx2.5 expression in the myocardial precursors in the
pharynx is greatly reduced by HH18, suggesting that
addition of myocardial precursor cells from the SHF is
complete by this stage. Although DiI/rhodamine labeling
experiments done at this later stage did demonstrateFig. 7. Model of addition of SHF. (A) Myocardium from the right SHF (red) spirals
which will become the pulmonary side of the outflow. Blue represents the putative
adds a myocardial component to the outflow tract (blue) and subsequently contribu
cardiac neural-crest-derived tunica media (green).movement of the SHF into the arterial pole, the cells did
not end up in the myocardium of the outflow tract. Instead,
they incorporated themselves into the caudal wall of the
aortic sac. This portion of the aortic sac will later make up
the vascular smooth muscle component of the outflow
vessels above the pulmonary and aortic valves (Fig. 6B and
Waldo et al., 2005a,b). Interestingly, it has been known for
many years that the tunica media contributed by the cardiac
neural crest ended at some distance above the valve, and the
source of the non-neural crest-derived vascular smooth
muscle at the base of the aorta and pulmonary trunk has
been unclear (Fig. 7). We now believe that the SHF is
responsible for this area of smooth muscle above the aortic
and pulmonary valves, and that this smooth muscle
component is added after the myocardial addition is
complete (Waldo et al., 2005a,b). This hypothesis is
supported by the ablation of the SHF at HH18, since these
embryos do not manifest problems with cardiac outflow
alignment but do have defects in the non-neural crest-
derived smooth muscle region.
Our data also demonstrate that the successful addition of
the SHF is required for correct formation of the coronary
arteries, since coronary artery anomalies are seen after both
the HH14 and 18 ablations. In the embryos ablated at HH14,
coronary artery anomalies are seen only in the most severely
affected embryos, indicating a more complete ablation of
both the early and the late components of the SHF in these
embryos. In the embryos ablated at HH18, only the later
component of SHF addition to the aortic sac is affected.
Since the later cells added from the SHF to the aortic sac
provide vascular smooth muscle at the base of the outflow
vessels, these experiments suggest that this later addition of
SHF to the aortic sac is required for appropriate targeting of
the coronary stems to the right and left coronary sinuses.
Thus, our work demonstrates that the SHF participates in
development of the cardiac outflow tract in two fundamental
ways. First, the SHF contributes cells to the myocardial wallbehind outflow and to the left side of the preseptation outflow myocardium
path of the left SHF anterior and to the right base of the outflow. (B) SHF
tes the vascular smooth muscle above the outflow valves (red) and below the
C. Ward et al. / Developmental Biology 284 (2005) 72–8382prior to HH18. This myocardium is added in a spiral with
right SHF contributing to the back and left side of the
outflow (Fig. 7A). After HH18, the SHF contributes to the
caudal wall of the aortic sac which is not added in a spiral
and will later become the vascular smooth muscle of the
outflow vessels above the valve. The two components added
to the outflow tract by the SHF together form the
myocardial/smooth muscle transition that occurs at the level
of the aortic and pulmonary valves (Fig. 7B). If both
components of the SHF are not added correctly, this
transition is disrupted. Our experiments suggest that the
coronaries require the later addition from the right SHF to
appropriately target their insertion into the aorta as ablation
of the right SHF at HH18 results in coronary artery defects.
However, it is also possible that the coronaries use the
myocardial/smooth muscle boundary to find their insertion
site into the aorta, and that the disruption of this boundary
leads to coronary artery anomalies.
Finally, the developmental defects seen after SHF
ablation (coronary artery anomalies, overriding aorta, and
pulmonary stenosis or atresia) are major components of
certain conotruncal heart defects, namely, double outlet
right ventricle and tetralogy of Fallot (Table 1). These
abnormalities are also seen after neural crest ablation and
represent major components of the DiGeorge phenotype in
humans. One of the underlying genetic disturbances in the
DiGeorge phenotype is microdeletion of chromosome
22q11. In fact, the prevalence of 22q11 deletions among
patients with tetralogy of Fallot is much higher in patients
with pulmonary atresia than in patients with tetralogy of
Fallot alone (Gelb, 1997). TBX1, a transcription factor
identified in the 22q11 region, is thought to be the major
determinant of the DiGeorge phenotype, since TBX1
mutations recapitulate the syndrome in mice. Recent work
by Xu et al. demonstrated that conditional deletion of TBX1
resulted in decreased cell proliferation in the secondary
heart field and that this occurred by a cell non-autonomous
mechanism (Xu et al., 2004). This work in conjunction with
the present study furthers the notion that tetralogy of Fallot
and double outlet right ventricle represent a subset of
congenital heart disease caused by defects in the secondary
heart field, since they can be recreated both mechanically
and genetically.
Point mutations in Nkx2.5 are also associated with
tetralogy of Fallot and pulmonary atresia in humans
(Benson et al., 1999; Goldmuntz et al., 2001). Teratogenic
and genetic models of tetralogy of Fallot and pulmonary
atresia have been described. Nitrofen induces many of the
defects in rats that are also seen in the DiGeorge phenotype
including tetralogy of Fallot and pulmonary atresia. Nitrofen
also causes congenital diaphragmatic hernia (Kim et al.,
1999; Losty et al., 1999). Interestingly, the splanchnic
mesoderm that forms the SHF in the ventral pharynx is
directly continuous with the somatic mesoderm that forms
the diaphragm, suggesting a link between these two
mesodermal fields.Our results suggest for the first time that tetralogy of
Fallot and pulmonary atresia represent the clinical manifes-
tation of disrupted addition of the SHF and indicate an
important role for the SHF in understanding the embryo-
genesis of these diseases.Acknowledgments
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